Gapping up
In reaction to strong earnings/guidance:
- BAC +0.9%
M&A news:
- ABCD +18.6% (enters into definitive merger agreement with Veritas Capital; Holders of common stock currently outstanding to receive $14.50/share in cash)
- LLL +5% (Harris (HRS) and L3 Technologies (LLL) to combine in merger of equals)
- HRS +3.5%
Select metals/mining stocks trading higher:
- DRD +13.7%, SBGL +6.8%, HMY +5.4%, CDE +4.6%, AU +3.6%, NEM +2.5%, AG +2.4%, BVN +2.2%, GG +2.2%, GOLD +2.1%, ABX +2%, GFI +1.8%, KGC +1.7%, GDX +1.5%, GLD +0.9%
Other news:
- ACRX +21.6% (confirms FDA Advisory Committee voted 10-3 in favor of recommending the approval of DSUVIA for the treatment of moderate-to-severe acute pain in adult patients)
- RKDA +10.2% (announced that the United States Patent and Trademark Office has granted the company a patent for extended shelf life wheat, the newest trait in Arcadia's non-genetically modified GoodWheat portfolio)
- EYPT +7.1% (receives FDA approval YUTIQ)
- TNDM +7% (received Heath Canada Medical Device License for the t:slim X2 Insulin Pump)
- RDY +1.4% (announces the sale of its API manufacturing business unit)
Analyst comments:
- LULU +1.5% (upgraded to Outperform from Neutral at Wedbush )
- ATVI +1.3% (upgraded to Overweight from Equal Weight at Barclays)
- APPN +1.3% (upgraded to Equal Weight from Underweight at Barclays)
- MTN +1.1% (upgraded to Outperform from Neutral at Macquarie)
![]()